Outcomes summary

Double-blind, randomized trial comparing topical acetylhexapeptide-3, palmitoyl pentapeptide-4 (Matrixyl), and placebo for crow’s feet, reporting measurable improvements in some subjects with palmitoyl pentapeptide-4 showing better overall results than comparator arms in this small study.

Limitations

Small sample size and short duration; cosmetic endpoints; results are formulation- and population-specific.

Notes

Primary source: PMID 36909866.